ArticleInternational journal of colorectal disease2019

MiR-218 and miR-100 polymorphisms as markers of irinotecan-based chemotherapy response in metastatic colorectal cancer.

Dimitra-Ioanna Lampropoulou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.